NCT04956497

Brief Summary

The data of patients undergo extracorporeal cardiopulmonary resuscitation (eCPR) will be collected and analyzed. This study will provide useful information about the indication, the start time and others to improve the outcome of ECPR.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 9, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

July 9, 2021

Status Verified

May 1, 2021

Enrollment Period

2.2 years

First QC Date

July 8, 2021

Last Update Submit

July 8, 2021

Conditions

Extracorporeal Membrane Oxygenation ComplicationCardiopulmonary Arrest

Outcome Measures

Primary Outcomes (1)

  • mortality rate

    the death rate of the patients

    28 days

Interventions

extracorporeal membrane oxygenation (ECMO)DEVICE

ECMO under ongoing cardiopulmonary resuscitation (eCPR) in patients with refractory cardiac arrest

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult (age\>=18y) cardiac arrested patients accept ECPR treatment will be enrolled in the study.

You may qualify if:

  • Age \>=18y
  • Cardiac arrested patients accept ECPR treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, 100730, China

Location

MeSH Terms

Conditions

Heart Arrest

Interventions

Extracorporeal Membrane Oxygenation

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Respiratory TherapyTherapeuticsExtracorporeal CirculationSurgical Procedures, Operative

Study Officials

  • Jun Xu, MD

    Peking Union Medical College Hospital

    STUDY CHAIR

Central Study Contacts

Jun Xu, MD

CONTACT

15801578819xunjunfree@126.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2021

First Posted

July 9, 2021

Study Start

September 1, 2021

Primary Completion

October 31, 2023

Study Completion

December 31, 2023

Last Updated

July 9, 2021

Record last verified: 2021-05

Locations

CN(1)